Literature DB >> 16710859

Therapeutic potential of sulfamides as enzyme inhibitors.

Jean-Yves Winum1, Andrea Scozzafava, Jean-Louis Montero, Claudiu T Supuran.   

Abstract

Sulfamide, a quite simple molecule incorporating the sulfonamide functionality, widely used by medicinal chemists for the design of a host of biologically active derivatives with pharmacological applications, may give rise to at least five types of derivatives, by substituting one to four hydrogen atoms present in it, which show specific biological activities. Recently, some of these compounds started to be exploited for the design of many types of therapeutic agents. Among the enzymes for which sulfamide-based inhibitors were designed, are the carbonic anhydrases (CAs), a large number of proteases belonging to the aspartic protease (HIV-1 protease, gamma-secretase), serine protease (elastase, chymase, tryptase, and thrombin among others), and metalloprotease (carboxypeptidase A (CPA) and matrix metalloproteinases (MMP)) families. Some steroid sulfatase (STS) and protein tyrosine phosphatase inhibitors belonging to the sulfamide class of derivatives have also been reported. In all these compounds, many of which show low nanomolar affinity for the target enzymes for which they have been designed, the free or substituted sulfamide moiety plays important roles for the binding of the inhibitor to the active site cavity, either by directly coordinating to a metal ion found in some metalloenzymes (CAs, CPA, STS), usually by means of one of the nitrogen atoms present in the sulfamide motif, or as in the case of the cyclic sulfamides acting as HIV protease inhibitors, interacting with the catalytically critical aspartic acid residues of the active site by means of an oxygen atom belonging to the HN-SO2-NH motif, which substitutes a catalytically essential water molecule. In other cases, the sulfamide moiety is important for inducing desired physico-chemical properties to the drug-like compounds incorporating it, such as enhanced water solubility, better bioavailability, etc., because of the intrinsic properties of this highly polarized moiety when attached to an organic scaffold. This interesting motif is thus of great value for the design of pharmacological agents with a lot of applications. 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710859     DOI: 10.1002/med.20068

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  26 in total

1.  Complementary regioselectivity in the Cu(I)-catalyzed diamination of conjugated dienes to form cyclic sulfamides.

Authors:  Richard G Cornwall; Baoguo Zhao; Yian Shi
Journal:  Org Lett       Date:  2010-12-30       Impact factor: 6.005

2.  Bidentate Zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry.

Authors:  Johannes Schulze Wischeler; Alessio Innocenti; Daniela Vullo; Arpita Agrawal; Seth M Cohen; Andreas Heine; Claudiu T Supuran; Gerhard Klebe
Journal:  ChemMedChem       Date:  2010-09-03       Impact factor: 3.466

3.  Effects of silica nanoparticle supported ionic liquid as additive on thermal reversibility of human carbonic anhydrase II.

Authors:  Azadeh Fallah-Bagheri; Ali Akbar Saboury; Leila Ma'mani; Mohammad Taghizadeh; Reza Khodarahmi; Samira Ranjbar; Mousa Bohlooli; Abbas Shafiee; Alireza Foroumadi; Nader Sheibani; Ali Akbar Moosavi-Movahedi
Journal:  Int J Biol Macromol       Date:  2012-07-22       Impact factor: 6.953

4.  Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides.

Authors:  Jung Ho Jun; Vineet Kumar; Thomas S Dexheimer; Iwona Wedlich; Marc C Nicklaus; Yves Pommier; Sanjay V Malhotra
Journal:  Eur J Pharm Sci       Date:  2017-10-13       Impact factor: 4.384

5.  Potent inhibition of Norwalk virus by cyclic sulfamide derivatives.

Authors:  Dengfeng Dou; Kok-Chuan Tiew; Guijia He; Sivakoteswara Rao Mandadapu; Sridhar Aravapalli; Kevin R Alliston; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem       Date:  2011-08-27       Impact factor: 3.641

6.  Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.

Authors:  Catlyn Blanchard; Pamela Barnett; Jessamyn Perlmutter; Paul M Dunman
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

7.  Anomeric Effects in Sulfamides.

Authors:  Eric Hansen; Elaine Limé; Per-Ola Norrby; Olaf Wiest
Journal:  J Phys Chem A       Date:  2016-05-10       Impact factor: 2.781

8.  Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors.

Authors:  Rajesh Subramaniam; Manas K Haldar; Shakila Tobwala; Bratati Ganguly; D K Srivastava; Sanku Mallik
Journal:  Bioorg Med Chem Lett       Date:  2008-04-16       Impact factor: 2.823

9.  Synthetic methodology for the preparation of N-hydroxysulfamides.

Authors:  Krishnaswamy Devanathan; Jennifer A Bell; Patricia C Wilkins; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2007-11-05       Impact factor: 2.415

10.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.

Authors:  Karina M Soares; Nicole Blackmon; Tong Ying Shun; Sunita N Shinde; Harold K Takyi; Peter Wipf; John S Lazo; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.